Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells

Raphael Wolfisberg, Kenn Holmbeck, Louise Nielsen, Amit Kapoor, Charles M. Rice, Jens Bukh, Troels K. H. Scheel

Journal of Virology · 2019 · 23 citations · 61 references

DOIFull text

Open access

Concepts

Abstract

A vaccine against hepatitis C virus (HCV) is crucial for global control of this important pathogen, which induces fatal human liver diseases. Vaccine development has been hampered by the lack of immunocompetent animal models. Discovery of rodent hepacivirus (RHV) enabled establishment of novel surrogate animal models. These allow robust infection and reverse genetic and immunization studies of laboratory animals, which develop HCV-like chronicity. Currently, there are no RHV in vitro systems available to study tropism and molecular virology. Here, we established the first culture systems for RHV, recapitulating the intracellular phase of the virus life cycle in vitro . These replicon systems enabled identification of replication-enhancing mutations and selection of cells highly permissive to RHV replication, which allow study of virus-host interactions. HCV antivirals targeting NS5A, NS5B, and microRNA-122 efficiently inhibited RHV replication. Hence, several important aspects of HCV replication are shared by the rodent virus system, reinforcing its utility as an HCV model.

References

61